Cargando…
Lambert-Eaton Myasthenic Syndrome; Pathogenesis, Diagnosis, and Therapy
Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare disease with a well-characterized pathogenesis. In 50% of the patients, LEMS is a paraneoplastic manifestation and caused by a small cell lung carcinoma (SCLC). Both LEMS patients with SCLC and those without this tumour have in 85% of cases pathogen...
Autor principal: | Gilhus, Nils Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182560/ https://www.ncbi.nlm.nih.gov/pubmed/21969911 http://dx.doi.org/10.4061/2011/973808 |
Ejemplares similares
-
Lambert-Eaton Myasthenic syndrome: early diagnosis is key
por: Ivanovski, Trajche, et al.
Publicado: (2019) -
Amifampridine for Lambert-Eaton myasthenic syndrome
Publicado: (2022) -
Lambert-Eaton Myasthenic Syndrome in Lung Cancer
por: Wang, Yongbin, et al.
Publicado: (2022) -
Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome
por: Bukhari, Sumera, et al.
Publicado: (2017) -
Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan
por: Yoshikawa, Hiroaki, et al.
Publicado: (2022)